Trial record 23 of 31 for:    alzheimer dijon

A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00890890
Recruitment Status : Terminated
First Posted : April 30, 2009
Last Update Posted : October 12, 2015
Information provided by (Responsible Party):
Bristol-Myers Squibb